Carla Meyer-Massetti

Prof. Dr. Carla Meyer-Massetti

University Hospital of Bern, Bern, Switzerland
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2010 in Journal of Hospital Medicine
Verified
Journal Article
Closed access
PDF file
CMCarla Meyer-Massetti
Carla Meyer-Massetti
CCChristine M Cheng
Christine M Cheng
BSBradley A Sharpe
Bradley A Sharpe
CMChristoph R Meier
Christoph R Meier
BGB. Joseph Guglielmo
B. Joseph Guglielmo

1 February 2011 in American Journal of Health-System Pharmacy
Verified
Journal Article
Closed access
PDF file
CMCarla Meyer-Massetti
Carla Meyer-Massetti
CCChristine M. Cheng
Christine M. Cheng
DSDavid Schwappach
David Schwappach
LPLynn Paulsen
Lynn Paulsen
BIBrigid Ide
Brigid Ide
BGB. Joseph Guglielmo
B. Joseph Guglielmo
Purpose The accuracy, efficiency, and efficacy of four commonly recommended medication safety assessment methodologies were systematically reviewed. Methods Medical literature databases were systematically searched for any comparative study conducted between January 2000 and October 2009 in which at least two of the four methodologies—incident report review, direct observation, chart review, and trigger tool—were compared with one another. Any study that compared two or more methodologies for quantitative accuracy (adequacy of the assessment of medication errors and adverse drug events) efficiency (effort and cost), and efficacy and that provided numerical data was included in the analysis. Results Twenty-eight studies were included in this review. Of these, 22 compared two of the methodologies, and 6 compared three methods. Direct observation identified the greatest number of reports of drug-related problems (DRPs), while incident report review identified the fewest. However, incident report review generally showed a higher specificity compared to the other methods and most effectively captured severe DRPs. In contrast, the sensitivity of incident report review was lower when compared with trigger tool. While trigger tool was the least labor-intensive of the four methodologies, incident report review appeared to be the least expensive, but only when linked with concomitant automated reporting systems and targeted follow-up. Conclusion All four medication safety assessment techniques—incident report review, chart review, direct observation, and trigger tool—have different strengths and weaknesses. Overlap between different methods in identifying DRPs is minimal. While trigger tool appeared to be the most effective and labor-efficient method, incident report review best identified high-severity DRPs.

11 January 2018 in International Journal of Clinical Pharmacy
Verified
Journal Article
Closed access
PDF file
CMCarla Meyer-Massetti
Carla Meyer-Massetti
CMChristoph R. Meier
Christoph R. Meier
BGB. Joseph Guglielmo
B. Joseph Guglielmo

1 January 2009 in Clinical Therapeutics
Verified
Journal Article
Closed access
CCChristine M. Cheng
Christine M. Cheng
CMCarla Meyer-Massetti
Carla Meyer-Massetti
SKSteven R. Kayser
Steven R. Kayser

21 July 2012 in International Journal of Clinical Pharmacy
Verified
Journal Article
Closed access
PDF file
DSDavid Schwappach
David Schwappach
CMCarla Meyer-Massetti
Carla Meyer-Massetti
KGKatrin Gehring
Katrin Gehring

5 October 2018 in International Journal of Clinical Pharmacy
Verified
Journal Article
Closed access
PDF file
CMCarla Meyer-Massetti
Carla Meyer-Massetti
VHVera Hofstetter
Vera Hofstetter
BHBarbara Hedinger-Grogg
Barbara Hedinger-Grogg
CMChristoph R. Meier
Christoph R. Meier
BGB. Joseph Guglielmo
B. Joseph Guglielmo